V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220014190 | 220008711 | null | 6.6 | Curative (C) | 2016-05-14 | 2016-05-15 | AML Int Guide ADE 8+3+5 (2) | 02 | N | 220032781 | ADE |
| 220014191 | 220008714 | 1.82 | 60 | Curative (C) | 2013-03-31 | 2013-04-09 | Idarubicin+Tretinoin Spanish Crse2 | N | N | 220032789 | IDARUBICIN + TRETINOIN |
| 220014192 | 220008716 | 1.66 | 6.9 | Curative (C) | 2013-06-19 | 2013-07-28 | CYCLOPHOSPHAMIDE + FLUDARABINE | null | null | 220032789 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220014193 | 220008717 | null | null | Curative (C) | 2015-07-22 | 2015-07-22 | ADE 8+3+5 | 02 | N | 220032790 | ADE |
| 220014197 | 220021910 | null | 0 | Curative (C) | 2017-01-16 | 2017-01-16 | FLAG | null | N | 220032803 | FLAG |
| 220014198 | 220022106 | null | 0 | Disease modification (D) | null | 2015-09-29 | BOSUTINIB | null | null | 220032803 | BOSUTINIB |
| 220014199 | 220022307 | 1.98 | 39.7 | Curative (C) | 2017-02-09 | 2017-02-09 | RUXOLITINIB | N | N | 220032807 | RUXOLITINIB |
| 220014200 | 220014691 | 1.63 | 74.2 | Curative (C) | null | 2017-12-05 | Triple / Double Intrathecal Therapy | N | null | 220032814 | TRIPLE INTRATHECAL |
| 220014201 | 220008723 | 1.8 | 82.9 | Curative (C) | 2014-01-05 | 2014-01-10 | FLAG | 2 | N | 220032820 | FLAG |
| 220014202 | 220014692 | 1.75 | 100.3 | Curative (C) | 2014-03-14 | 2014-10-03 | IDARUBICIN + TRETINOIN | Y | N | 220032828 | IDARUBICIN + TRETINOIN |
| 220014203 | 220014692 | null | 62.95 | Disease modification (D) | 2013-11-02 | 2013-11-02 | ATG + Busulfan + Fludarabine | N | null | 220032828 | ATG + BUSULFAN + FLUDARABINE |
| 220014204 | 220008724 | 1.88 | 13.1 | Curative (C) | 2013-10-23 | 2013-10-23 | AML Int Guide ADE 8+3+5 (2) | N | null | 220032836 | ADE |
| 220014205 | 220008725 | 1.83 | 70 | Curative (C) | null | 2018-03-25 | ATG + Busulfan + Fludarabine | N | N | 220032838 | ATG + BUSULFAN + FLUDARABINE |
| 220014206 | 220008725 | 0 | null | Curative (C) | 2015-08-28 | 2015-08-28 | IDARUBICIN + TRETINOIN | N | N | 220032838 | IDARUBICIN + TRETINOIN |
| 220014207 | 220008725 | 1.75 | 57.7 | Curative (C) | 2015-09-20 | 2015-09-20 | Cyclophosphamide+Fludara+TBI Allo | null | N | 220032838 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220014208 | 220008725 | 1.72 | 113.8 | Curative (C) | 2013-02-14 | 2013-02-14 | AML16 Low Dose Cytarabine | N | N | 220032838 | AML16 TRIAL |
| 220014209 | 220008726 | 1.73 | 78.3 | Curative (C) | null | 2013-03-29 | ATG + Busulfan + Fludarabine | N | N | 220032855 | ATG + BUSULFAN + FLUDARABINE |
| 220014210 | 220008728 | 1.5 | 90 | Curative (C) | 2015-04-11 | 2015-06-06 | BOSUTINIB | 02 | Y | 220032856 | BOSUTINIB |
| 220014211 | 220008733 | null | null | Curative (C) | 2016-06-04 | 2016-06-04 | IDARUBICIN + TRETINOIN | N | N | 220032862 | IDARUBICIN + TRETINOIN |
| 220014212 | 220008734 | 1.65 | 55 | Curative (C) | 2017-01-12 | 2017-01-15 | RUXOLITINIB | 02 | N | 220032862 | RUXOLITINIB |
| 220014213 | 220008737 | 1.75 | 83.8 | Curative (C) | 2015-11-03 | 2015-11-03 | Methotrexate intrathecal | N | N | 220032865 | METHOTREXATE INTRATHECAL |
| 220014214 | 220008738 | 1.6 | 56.7 | Curative (C) | 2015-09-16 | 2015-12-21 | BOSUTINIB | N | N | 220032865 | BOSUTINIB |
| 220014215 | 220014698 | null | null | Curative (C) | 2017-05-25 | 2017-05-25 | AML16 Low Dose Cytarabine | N | N | 220032871 | AML16 TRIAL |
| 220014216 | 220008740 | 1.66 | 75 | Curative (C) | 2018-02-02 | 2018-02-05 | BOSUTINIB | N | N | 220032871 | BOSUTINIB |
| 220014217 | 220008744 | 1.17 | 79.3 | Curative (C) | 2014-10-06 | 2014-11-18 | BOSUTINIB | Y | null | 220032874 | BOSUTINIB |
| 220014218 | 220014700 | 1.65 | null | Curative (C) | 2014-09-17 | 2014-09-17 | Cyclophosphamide+Fludara+TBI Allo | N | null | 220032874 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220014219 | 220014700 | 1.65 | 55.95 | Curative (C) | 2018-03-31 | 2018-04-01 | CYCLOPHOSPHAMIDE + FLUDARABINE | 02 | N | 220032874 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220014220 | 220014701 | 0 | 71 | Curative (C) | 2015-03-17 | 2015-03-25 | AML16 DA 3+8 | 2 | N | 220032881 | AML16 TRIAL |
| 220014221 | 220019892 | 1.58 | 60.3 | Curative (C) | 2017-05-27 | 2017-05-27 | FLAG | N | N | 220032886 | FLAG |
| 220014222 | 220008747 | 1.76 | 72.5 | Curative (C) | 2013-01-29 | 2013-02-02 | Cyclophosphamide TBI Allograft | N | N | 220032887 | CYCLOPHOSPHAMIDE |
| 220014223 | 220008748 | 1.77 | 17.5 | null | null | 2016-12-11 | Triple Intrathecal | N | N | 220032887 | TRIPLE INTRATHECAL |
| 220014224 | 220018031 | 1.59 | 5.8 | Curative (C) | 2017-09-03 | 2017-09-09 | FLAG | 2 | N | 220032899 | FLAG |
| 220014225 | 220008750 | 1.51 | 53.1 | Curative (C) | 2016-02-15 | 2016-12-06 | FLAG | N | N | 220032900 | FLAG |
| 220014226 | 220008751 | 1.85 | 12.4 | Curative (C) | 2017-10-23 | 2017-10-26 | Cyclophosphamide+Fludara+TBI Allo | N | N | 220032905 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220014227 | 220008752 | null | null | Curative (C) | 2017-12-19 | 2017-12-20 | Idarubicin+Tretinoin Spanish Crse2 | 02 | N | 220032908 | IDARUBICIN + TRETINOIN |
| 220014228 | 220008755 | 1.55 | null | Curative (C) | 2015-08-08 | 2015-09-21 | ATG + Busulfan + Fludarabine | 02 | null | 220032911 | ATG + BUSULFAN + FLUDARABINE |
| 220014229 | 220008759 | 1.7 | 119 | Curative (C) | null | 2017-10-18 | RUXOLITINIB | N | N | 220032917 | RUXOLITINIB |
| 220014230 | 220008760 | 1.73 | 94.25 | Curative (C) | 2014-02-17 | 2014-10-02 | RUXOLITINIB | N | N | 220032919 | RUXOLITINIB |
| 220014231 | 220008762 | null | 83.2 | Curative (C) | 2015-07-26 | 2015-07-26 | ATG + Busulfan + Fludarabine | 2 | N | 220032920 | ATG + BUSULFAN + FLUDARABINE |
| 220014232 | 220008764 | 1.67 | 133.5 | null | 2013-11-01 | 2013-11-01 | Cyclophosphamide TBI Allograft | null | null | 220032927 | CYCLOPHOSPHAMIDE |
| 220014233 | 220014706 | null | 60 | Curative (C) | 2017-04-14 | 2017-04-14 | IDARUBICIN + TRETINOIN | N | null | 220032932 | IDARUBICIN + TRETINOIN |
| 220014234 | 220008766 | 1.63 | 16.2 | Curative (C) | 2018-01-09 | 2018-02-11 | BOSUTINIB | 02 | N | 220032935 | BOSUTINIB |
| 220014235 | 220014708 | 1.51 | 55 | Curative (C) | 2015-10-08 | 2015-10-09 | FLAG | 02 | N | 220032935 | FLAG |
| 220014236 | 220018034 | 1.8 | 88.8 | Curative (C) | 2016-10-05 | 2016-10-05 | Idarubicin+Tretinoin Spanish Crse4 | N | N | 220032948 | IDARUBICIN + TRETINOIN |
| 220014237 | 220018034 | 1.81 | 84.5 | Curative (C) | 2016-03-20 | 2016-03-20 | FLAG | 02 | Y | 220032948 | FLAG |
| 220014238 | 220021572 | 1.67 | 46 | Curative (C) | 2017-07-23 | 2017-07-28 | FLAG | 02 | N | 220032956 | FLAG |
| 220014239 | 220008768 | 1.74 | 110 | Curative (C) | 2016-05-23 | 2016-05-24 | Methotrexate intrathecal | 2 | N | 220032973 | METHOTREXATE INTRATHECAL |
| 220014240 | 220008771 | 1.68 | null | Palliative (P) | 2016-07-28 | 2017-04-12 | AML16 DA 3+8 | N | N | 220032980 | AML16 TRIAL |
| 220014241 | 220008774 | 1.7 | 60 | Curative (C) | 2013-10-18 | 2013-10-22 | CYCLOPHOSPHAMIDE + FLUDARABINE | 2 | Y | 220032982 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220014242 | 220014712 | 0 | 7.1 | Curative (C) | 2016-05-26 | 2016-05-26 | Idarubicin+Tretinoin Spanish Crse2 | N | N | 220032988 | IDARUBICIN + TRETINOIN |